Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22439
Buy Now

Azithromycin Prices December 2023

Category Region Price
Azithromycin Pharma API USA 122750 USD/MT (Azithromycin Dihydrate) US, FDA
Azithromycin Pharma API China 120000 USD/MT (Azithromycin Dihydrate) US, FDA
Azithromycin Pharma API Germany 122195 USD/MT (Azithromycin Dihydrate) US, FDA

The price of azithromycin in the USA for Q4 2023 was 122750 USD/MT (Azithromycin Dihydrate) US, FDA. It saw a decline due to diminished demand, with market participants prioritizing the destocking of old inventories. The overall growth in new orders remained minimum and the decline in international trade persisted.

In China, the price of azithromycin witnessed a notable reduction, reaching reached 120000 USD/MT (Azithromycin Dihydrate) US, FDA, attributed to the decreased order inquiries from both domestic and international markets. The decline in the domestic market was because of the growing concerns about antibiotic resistance, especially the excessive utilization of azithromycin.

Germany saw a drop in azithromycin prices, reaching 122195 USD/MT (Azithromycin Dihydrate) US, FDA, in December owing to the decreased demand from the healthcare and pharmaceutical industries as well as the return of inflation and persistently high interest rates. Companies and individuals cut back on investments and spending due to the current economic climate, which decreased demand for azithromycin and thus drove down prices.

Azithromycin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of azithromycin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of azithromycin at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of azithromycin price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing azithromycin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Azithromycin Price Trend

Azithromycin Market Analysis

The global azithromycin market size reached US$ 7.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 11.9 Billion, at a projected CAGR of 5.50% during 2023-2032.

  • The increasing prevalence of chronic obstructive pulmonary disease (COPD) among the masses due to long-term exposure to irritating chemicals or particulate matter, especially from cigarette smoke, is strengthening the market growth. Azithromycin helps in the management of COPD by reducing the frequency of exacerbations and alleviating symptoms. According to America Lung Association, COPD was the sixth leading cause of mortality overall and the fifth leading cause of disease-related death in 2021, with 138,825 deaths attributed to the condition. Notably, more women (72,727) than men (66,098) died from COPD, yet men showed a higher mortality rate from the disease, with 36.8 deaths per 100,000 compared to 31.5 deaths per 100,000 in women.
  • The growing geriatric population that is more susceptible to numerous bacterial infections due to weakened immune systems is offering a favorable market outlook. Azithromycin is useful in treating respiratory, urinary, and skin infections among the older demographics. Additionally, its simple dosage schedule makes it easier for elderly patients to adhere to medication regimen. As per the World Health Organization (WHO), 1 in 6 people globally will be aged 60 years or older by 2050, with the population in this age group increasing from 1 billion in 2020 to 1.4 billion. Furthermore, the number of individuals aged 60 years and older is projected to double to 2.1 billion, while the population aged 80 years or older is anticipated to triple to reach 426 million by 2050.
  • The rising emergence of antibiotic-resistant strains of bacteria is catalyzing the demand for azithromycin, which is effective against certain drug-resistant bacteria. Its favorable safety profile positions it as a valuable therapeutic option in combating antibiotic resistance. Based on the data provided by the World Bank, antimicrobial resistance (AMR) could lead to an additional US$1 trillion in healthcare costs by 2050. Moreover, it could result in annual gross domestic product (GDP) losses ranging from US$1 trillion to US$3.4 trillion by 2030. These estimates highlight the urgent need for comprehensive strategies to address and mitigate the impact of AMR on both public health and global economies.
  • The increasing incidence of bacterial infections, including respiratory tract infections, sexually transmitted diseases (STDs), and skin infections, is catalyzing the demand for azithromycin due to its effectiveness against various bacterial pathogens.

Azithromycin News

The report covers the latest developments, updates, and trends impacting the global azithromycin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in azithromycin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the azithromycin price trend.

Latest developments in the azithromycin industry:

  • In April 2023: Zydus Lifesciences Limited obtained final approval from the United States Food and Drug Administration (USFDA) for the production and distribution of Azithromycin Tablets USP, 500 mg (USRLD: Zithromax Tablets).
  • In January 2023: Poly Pharmaceutical Co., Ltd. achieved market approval from the Israeli Ministry of Health's Pharmacy Division for the sale of Azithromycin injection, marking eligibility for sales in the Israeli market. Prior approvals for Bivalirudin injection and Ganciclovir injection in January and July 2023 respectively, also contribute to Poly Pharmaceutical's expansion in Israel.
  • In January 2023: Pfizer Inc. and the International Trachoma Initiative donated the one billionth Zithromax® (azithromycin) dose, supporting the trachoma elimination strategy of WHO. This milestone follows the commitment of Pfizer to extend its antibiotic donation program until 2030, aiding 18 countries in their efforts to combat trachoma.

Product Description

Azithromycin is an antibiotic belonging to the macrolide class, created to combat a wide range of bacterial infections. It is synthesized through a complex process of fermentation, followed by a series of chemical reactions that introduce a methyl-substituted nitrogen atom into the lactone ring of erythromycin A. It is available in multiple forms, including oral tablets, capsules, suspension, and an intravenous formulation, catering to various patient needs and preferences.

It is incorporated into personal care products owing to its antibacterial properties. It may be present in skincare products targeting acne or other bacterial skin conditions, providing both therapeutic and preservative effects. It is also utilized in the agriculture sector to combat bacterial infections in crops and plants.

Regional Coverage

The report provides a detailed analysis of the azithromycin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the azithromycin price trend.

Global Azithromycin Price

The report offers a holistic view of the global azithromycin pricing trends in the form of azithromycin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of azithromycin but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed azithromycin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Azithromycin Price

In the European region, azithromycin pricing was shaped by multiple factors. October saw a decline attributed to subdued user sentiments, elevated interest rates, and ample supply. However, inflation sharply dropped due to lower fuel prices and swift interest rate hikes, reducing market demand and prices. Prices rebounded in November with increased demand from pharmaceutical and healthcare sectors, heightened individual spending, and reduced inventories.

This analysis can be extended to include detailed azithromycin price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Azithromycin Price

In the North American azithromycin market prices were influenced by inflation, interest rates, and geopolitical tensions, resulting in a bearish sentiment and price decline compared to the previous year. October saw notable price fluctuations due to subdued domestic demand and abundant inventories, leading to decreased prices. However, signs of inflation easing in November led to higher individual spending and increasing prices.

Specific azithromycin historical data within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada

Middle East and Africa Azithromycin Price

The report explores the azithromycin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on azithromycin prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Azithromycin Price

In Q4 2023, the Asia Pacific azithromycin market experienced notable price fluctuations. October saw a downturn attributed to reduced demand and oversupply, particularly due to a manufacturing sector contraction. However, November showed improvement with increased supply, demand, and manufacturer optimism, leading to rising prices. Heightened inquiries from downstream industries, notably the healthcare sector during the winter season, contributed to the upward trend.

This azithromycin price analysis can be expanded to include a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Azithromycin Price

The analysis of azithromycin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Report Coverage

Key Attributes Details
Product Name Azithromycin
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Azithromycin Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of azithromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting azithromycin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The azithromycin price charts ensure our clients remain at the forefront of the industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More